Serum Neuron-specific Enolase Levels in Preterm and Term Newborns and in Infants 1–3 Months of Age
- 1 April 2015
- journal article
- Published by Elsevier BV in Pediatrics & Neonatology
- Vol. 56 (2), 114-119
- https://doi.org/10.1016/j.pedneo.2014.07.005
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Clinical neuropathology practice guide 5-2013: markers of neuronal maturationClinical Neuropathology, 2013
- Neonatal suprarenal mass: differential diagnosis and treatmentZeitschrift für Krebsforschung und Klinische Onkologie, 2012
- Neurological injury markers in children with septic shock*Pediatric Critical Care Medicine, 2008
- Elevated serum levels of S-100β protein and neuron-specific enolase are associated with brain injury in patients with severe sepsis and septic shock*Critical Care Medicine, 2006
- Neuron-specific enolase as a marker of the severity and outcome of hypoxic ischemic encephalopathyBrain & Development, 2004
- Auditory neuropathy in hyperbilirubinemia: is there a correlation between serum bilirubin, neuron-specific enolase levels and auditory neuropathy?International Journal of Audiology, 2004
- Brain damage markers in children. Neurobiological and clinical aspectsActa Paediatrica, 2002
- S-100b and neuron-specific enolase in patients with fulminant hepatic failureLiver Transplantation, 2001
- Clinical biochemistry of neuron specific enolaseClinica Chimica Acta; International Journal of Clinical Chemistry, 1989
- Neuron Specific Enolase, A Clinically Useful Marker for Neurons and Neuroendocrine CellsAnnual Review of Neuroscience, 1987